CIK: 1461241 - Address: C/o Cadila Pharmaceuticals Ltd, Cadila, Corporate Campus, Sarkhej- Dholka Road, Bhat, Ahmedabad Gujarat, K7 382 210
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret118-24213313612
S%wins6338130756342

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/18/15 16:43
6/16/15
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagModi Rajiv I.K7DS.m-3,9029.0122-433-152,500I37610362-416332-218285-14-30
6/15/15 17:10
6/11/15
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagModi Rajiv I.K7DS-1019.0021-1102,933I3669655-412000163713-7-28
6/10/15 17:34
6/8/15
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagModi Rajiv I.K7DS.m-4,9458.9722-551-162,944I37610464-192-12003518-10-26
6/4/15 17:13
6/2/15
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagModi Rajiv I.K7DS.m-4,5008.9224-505-133,495I37187741550-1132420-2-28
6/1/15 16:39
5/28/15
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagModi Rajiv I.K7DS.m-30,6008.7423-3,500-474,000I3488371-212931-1-11830-11-34
11/21/14 16:50
11/20/14
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagModi Rajiv I.K7DS-2,6055.0226-519-67,500I1986241115-10-533517847541
11/18/14 20:45
11/17/14
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagModi Rajiv I.K7DS.m-7,4065.0026-1,481-168,019I2126111713-11-5-6-3518877850
3/21/14 17:50
3/19/14
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagModi Rajiv I.K7DS.m-14,8504.9532-3,000-249,500I2591305511-5-23-16-6-12-7-103-499

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact